Key result
Dual antiplatelet therapy after stent-assisted coiling in patients with aneurysmal subarachnoid hemorrhage did not increase shunt-related complications compared to coiling alone.
Why the study?
Does dual antiplatelet therapy affect shunt-related complications and long-term functional outcomes in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular treatment?
Cohort (n=25)
No
Does dual antiplatelet therapy affect shunt-related complications and long-term functional outcomes in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular treatment?
In a small pilot cohort of aSAH patients, DAPT after stent-assisted coiling did not significantly increase shunt-related complications or worsen long-term functional outcomes compared to coiling alone.
Answers are grounded in this paper and cite their sources.
No excess shunt complications or poor outcomes with DAPT after stent coiling in aSAH; hypothesis-generating, needs larger prospective confirmation.
OBJECTIVE: The aim of this retrospective, matched cohort study is to determine the effect of dual antiplatelet therapy (DAPT) on shunt-related complications and long-term functional outcomes in endovascularly treated aneurysmal subarachnoid hemorrhage (aSAH) patients. MATERIALS AND METHOD: We retrospectively analyzed an institutional database of aSAH patients from 2000-2015. Patients who underwent endovascular treatment with stent-assisted coiling (DAPT cohort) were matched in a 1:4 ratio to those who underwent coiling alone (no-DAPT cohort) based on the presenting patient and aneurysm factors. A favorable outcome was defined as a modified Rankin scale of <2. Statistical analyses were performed to compare the shunt-related and functional outcomes between the DAPT and no-DAPT cohorts. RESULTS: After applying the selection criteria and performing the matching process, the overall study cohort comprised 25 aSAH patients who underwent endovascular treatment, including five in the DAPT and 20 in the no-DAPT cohorts. The mean age, World Federation of Neurological Surgeons grade, aneurysm size, and follow-up duration of the overall study cohort were 52.3 years, 2.9, 7.4 mm, and 32.7 months, respectively. The mean time from aSAH to shunt placement was significantly higher for patients in the DAPT cohort (5.6 vs. 0.7 months; p=0.026). The shunt complication rates (p=0.562) and functional outcomes at last follow-up (p=0.924) were not significantly different between the two cohorts. CONCLUSION: Patients receiving DAPT after the stent-assisted coiling of acutely ruptured aneurysms do not have an increased risk of shunt-related complications or unfavorable long-term functional outcomes compared to endovascularly treated aSAH patients not taking DAPT. These results suggest that further study is warranted.
No takes yet. Share an insight, caveat, or question.
Paisan et al. (2018) conducted a cohort in Aneurysmal subarachnoid hemorrhage with shunt-dependent hydrocephalus (n=25). Dual antiplatelet therapy (DAPT) after stent-assisted coiling vs. Coiling alone without DAPT was evaluated on Shunt complications (p=0.562). Dual antiplatelet therapy after stent-assisted coiling in patients with aneurysmal subarachnoid hemorrhage did not increase shunt-related complications compared to coiling alone.
Synapse has enriched 10 related papers. Consider them for comparative context: